Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A Randomized, Double-Blind Study of the Efficacy and Safety of Valdecoxib Compared to Placebo for Treatment of Post- Cholecystectomy Surgery Pain

ClinicalTrials.gov ID: NCT00661635

Public ClinicalTrials.gov record NCT00661635. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 2:43 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multiple-Dose, Randomized, Double-Blind, Placebo-Controlled Study of the Analgesic Efficacy and Safety of Valdecoxib Compared to Placebo in Patients for Treatment of Post-Surgical Pain From Laparoscopic Cholecystectomy Surgery

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To evaluate the analgesic efficacy, general safety, and effects on health outcome measures and opioid-related symptoms of 2 valdecoxib dosing regimens compared with placebo in patients with moderate or severe pain following laparoscopic cholecystectomy surgery.

Study identification

NCT ID
NCT00661635
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer
Industry
Enrollment
490 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 2002 (Type not available)
Primary completion
Not listed
Completion
Jul 2003 (Actual)
Last update posted
Apr 23, 2008

2002 – 2003

United States locations

U.S. sites
65
U.S. states
20
U.S. cities
50
Facility City State ZIP Site status
Pfizer Investigational Site Birmingham Alabama 35213 —
Pfizer Investigational Site Daphne Alabama 36526 —
Pfizer Investigational Site Fairhope Alabama 36532 —
Pfizer Investigational Site Mobile Alabama 36617 —
Pfizer Investigational Site Mobile Alabama 36693 —
Pfizer Investigational Site Sheffield Alabama 35660 —
Pfizer Investigational Site Glendale Arizona 85306 —
Pfizer Investigational Site Glendale Arizona 85308 —
Pfizer Investigational Site Phoenix Arizona 85006 —
Pfizer Investigational Site Phoenix Arizona 85020 —
Pfizer Investigational Site Phoenix Arizona 85023 —
Pfizer Investigational Site Phoenix Arizona 85027 —
Pfizer Investigational Site Tucson Arizona 85710 —
Pfizer Investigational Site Tucson Arizona 85711 —
Pfizer Investigational Site Tucson Arizona 85712 —
Pfizer Investigational Site Anaheim California 92801 —
Pfizer Investigational Site Bakersfield California 93309 —
Pfizer Investigational Site Bakersfield California 93311 —
Pfizer Investigational Site Los Angeles California 90017 —
Pfizer Investigational Site Los Angeles California 90057 —
Pfizer Investigational Site Pasadena California 91109 —
Pfizer Investigational Site Sacramento California 95817 —
Pfizer Investigational Site San Jose California 95124 —
Pfizer Investigational Site Woodland California 95695 —
Pfizer Investigational Site Miami Florida 33136 —
Pfizer Investigational Site Miami Florida 33176 —
Pfizer Investigational Site Pensacola Florida 32504 —
Pfizer Investigational Site Blue Ridge Georgia 30513 —
Pfizer Investigational Site Marietta Georgia 30060 —
Pfizer Investigational Site Chicago Illinois 60611 —
Pfizer Investigational Site Maywood Illinois 60153 —
Pfizer Investigational Site Iowa City Iowa 52242 —
Pfizer Investigational Site Shreveport Louisiana 71105 —
Pfizer Investigational Site Baltimore Maryland 21229 —
Pfizer Investigational Site Germantown Maryland 20874 —
Pfizer Investigational Site Rockville Maryland 20850 —
Pfizer Investigational Site Silver Spring Maryland 20902 —
Pfizer Investigational Site Jackson Mississippi 39202 —
Pfizer Investigational Site Durham North Carolina 27710 —
Pfizer Investigational Site Winston-Salem North Carolina 27103-3315 —
Pfizer Investigational Site Winston-Salem North Carolina 27103 —
Pfizer Investigational Site Oklahoma City Oklahoma 73104 —
Pfizer Investigational Site Allentown Pennsylvania 18103 —
Pfizer Investigational Site Philadelphia Pennsylvania 19107-4998 —
Pfizer Investigational Site Pittsburgh Pennsylvania 15212 —
Pfizer Investigational Site Charleston South Carolina 29406 —
Pfizer Investigational Site Columbia South Carolina 29203 —
Pfizer Investigational Site Columbia South Carolina 29209 —
Pfizer Investigational Site Mt. Pleasant South Carolina 29464 —
Pfizer Investigational Site North Charleston South Carolina 29406 —
Pfizer Investigational Site Summerville South Carolina 29485 —
Pfizer Investigational Site Bristol Tennessee 37620 —
Pfizer Investigational Site Kingsport Tennessee 37660 —
Pfizer Investigational Site Houston Texas 77024 —
Pfizer Investigational Site Houston Texas 77055 —
Pfizer Investigational Site San Antonio Texas 78224 —
Pfizer Investigational Site Universal City Texas 78148 —
Pfizer Investigational Site Sandy City Utah 84070 —
Pfizer Investigational Site Sandy City Utah 84094 —
Pfizer Investigational Site West Jordan Utah 84088 —
Pfizer Investigational Site Norfolk Virginia 23517 —
Pfizer Investigational Site Suffolk Virginia 23434 —
Pfizer Investigational Site Renton Washington 98055 —
Pfizer Investigational Site Renton Washington 98058-5010 —
Pfizer Investigational Site Madison Wisconsin 53792 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00661635, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 23, 2008 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00661635 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →